Vivos (RDGL) Gross Margin Growth (5y) (2016 - 2023)
Vivos (RDGL) Gross Margin Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -6,873.00 |
| Mar 31, 2022 | 61,822.00 |
| Sep 30, 2021 | 158,759.00 |
| Mar 31, 2018 | -3,849.00 |
| Mar 31, 2017 | -62,999.00 |
| Sep 30, 2016 | -159,708.00 |
| Jun 30, 2016 | -354,539.00 |
| Mar 31, 2016 | -25,222.00 |